The latest quarterly R&D expense is $4.33 Million with a QoQ Growth of +10.78%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $4.33M.
$4.33M
$4.33 Million
Q2 FY2026 · 2026-06-30
+10.78%
vs. $3.90M prior quarter
21
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $4.33M | +10.78% | +38.43% |
| Q1 FY2026Period end 2026-03-31 | $3.90M | +3.91% | +36.06% |
| Q4 FY2025Period end 2025-12-31 | $3.76M | +19.45% | +43.87% |
| Q3 FY2025Period end 2025-09-30 | $3.15M | +0.67% | +21.84% |
| Q2 FY2025Period end 2025-06-30 | $3.13M | +8.89% | +33.09% |
| Q1 FY2025Period end 2025-03-31 | $2.87M | +9.88% | -0.86% |
| Q4 FY2024Period end 2024-12-31 | $2.61M | +1.16% | -66.90% |
| Q3 FY2024Period end 2024-09-30 | $2.58M | +9.97% | -74.21% |
| Q2 FY2024Period end 2024-06-30 | $2.35M | -18.89% | -79.94% |
| Q1 FY2024Period end 2024-03-31 | $2.90M | -63.32% | -69.21% |
| Q4 FY2023Period end 2023-12-31 | $7.89M | -21.17% | -22.60% |
| Q3 FY2023Period end 2023-09-30 | $10.01M | -14.48% | -4.63% |
| Q2 FY2023Period end 2023-06-30 | $11.71M | +24.49% | +54.66% |
| Q1 FY2023Period end 2023-03-31 | $9.40M | -7.79% | +59.89% |
| Q4 FY2022Period end 2022-12-31 | $10.20M | -2.86% | +66.67% |
| Q3 FY2022Period end 2022-09-30 | $10.50M | +38.68% | +131.77% |
| Q2 FY2022Period end 2022-06-30 | $7.57M | +28.70% | +86.70% |
| Q1 FY2022Period end 2022-03-31 | $5.88M | -3.87% | N/A |
| Q4 FY2021Period end 2021-12-31 | $6.12M | +35.09% | N/A |
| Q3 FY2021Period end 2021-09-30 | $4.53M | +11.72% | N/A |
| Q2 FY2021Period end 2021-06-30 | $4.05M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
